Clinical Trials Logo

Clinical Trial Summary

Heart damage by copper accumulation has been reported in Wilson's Disease. However, the disease epidemiology is still poorly understood. A number of studies on pediatric populations have not shown any significant cardiac involvement apart from early dysautonomia. This could suggest that the clinical manifestations related to the copper accumulation in the heart appears with the duration of the disease. Case-control studies on adult populations have highlighted various electrocardiographic (ECG) abnormalities more frequent in patients with Wilson's Disease than in healthy volunteers, but all these studies involved small number of patients (maximum 60). The hypothesis is that there is cardiac involvement in Wilson's Disease, requiring screening, follow-up and appropriate support.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05493605
Study type Interventional
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact Amélie YAVCHITZ
Phone 01 48 03 64 54
Email ayavhitz@for.paris
Status Recruiting
Phase N/A
Start date March 2, 2023
Completion date March 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04537377 - A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease Phase 1/Phase 2
Not yet recruiting NCT06051734 - Early Detection of Cardiac Affection in Patients of Wilson's Disease
Active, not recruiting NCT02252380 - ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders N/A
Completed NCT01874028 - A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients Phase 1
Recruiting NCT05183165 - Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease N/A
Completed NCT00212355 - Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. Phase 3
Recruiting NCT03957720 - The Individual Therapy for Patients With Wilson's Disease Early Phase 1
Recruiting NCT05239858 - International Wilson's Disease Patient Registry (iWilson Registry)
Recruiting NCT04012658 - A Registered Cohort Study on Wilson's Disease
Completed NCT02552628 - WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation) N/A
Completed NCT06128954 - Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily). Phase 1
Recruiting NCT05305872 - Gandouling in the Treatment of Wilson's Disease Phase 4
Recruiting NCT04212195 - Cohort Research on Wilson's Disease
Completed NCT01378182 - Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis N/A